Clinical Trial Update: Study of Tumor Treating Fields With Hypofractionated Chemoradiotherapy in Newly Diagnosed Glioblastoma [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating tumor treating fields with hypofractionated chemoradiotherapy in newly diagnosed glioblastoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Stanford University | Conditions: Glioblastoma, Newly Diagnosed Glioblastoma | Phase 1 | Status: COMPLETED